BioSpace News Archive

Novotech Health Holdings, the largest biotech specialist contract research organization in Asia, announced the appointment of Andy Liu as Head of China.

Lattice Biologics Ltd. announces financial results for Q4 2020 and year end 2020.

Neuronetics, Inc., a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced that it has priced the previously announced underwritten public offering of 4,840,000 shares of its common stock, at a public offering price of $15.50 per share.

Data presented have been submitted to U.S. and EU regulatory agencies and represent an important step towards addressing the high unmet need in this patient population

CTI BioPharma Corp. announced that the Compensation Committee of its Board of Directors granted equity awards to two new employees with a grant date of January 28, 2021, as equity inducement awards outside of the Company’s Amended and Restated 2017 Equity Incentive Plan and material to the employees’ acceptance of employment with the company.

Senseonics Holdings, Inc. announced the closing on January 26, 2021, of its previously announced public underwritten offering of 59,740,259 shares of common stock of the Company, including the exercise in full by the underwriter of its option to purchase an additional 7,792,207 shares of common stock which closed yesterday, at a public offering price of $1.925 per share.